» Articles » PMID: 36725082

Central Lung Gene Expression Associates with Myofibroblast Features in Idiopathic Pulmonary Fibrosis

Abstract

Rationale: Contribution of central lung tissues to pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unknown.

Objective: To ascertain the relationship between cell types of IPF-central and IPF-peripheral lung explants using RNA sequencing (RNA-seq) transcriptome.

Methods: Biopsies of paired IPF-central and IPF-peripheral along with non-IPF lungs were selected by reviewing H&E data. Criteria for differentially expressed genes (DEG) were set at false discovery rate <5% and fold change >2. Computational cell composition deconvolution was performed. Signature scores were computed for each cell type.

Findings: Comparison of central IPF versus non-IPF identified 1723 DEG (1522 upregulated and 201 downregulated). Sixty-two per cent (938/1522) of the mutually upregulated genes in central IPF genes were also upregulated in peripheral IPF versus non-IPF. Moreover, 85 IPF central-associated genes (CAG) were upregulated in central IPF versus both peripheral IPF and central non-IPF. IPF single-cell RNA-seq analysis revealed the highest CAG signature score in myofibroblasts and significantly correlated with a previously published activated fibroblasts signature (r=0.88, p=1.6×10). CAG signature scores were significantly higher in IPF than in non-IPF myofibroblasts (p=0.013). Network analysis of central-IPF genes identified a module significantly correlated with the deconvoluted proportion of myofibroblasts in central IPF and anti-correlated with inflammation foci trait in peripheral IPF. The module genes were over-represented in idiopathic pulmonary fibrosis signalling pathways.

Interpretation: Gene expression in central IPF lung regions demonstrates active myofibroblast features that contributes to disease progression. Further elucidation of pathological transcriptomic state of cells in the central regions of the IPF lung that are relatively spared from morphological rearrangements may provide insights into molecular changes in the IPF progression.

Citing Articles

An FGF2-Derived Short Peptide Attenuates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting Collagen Deposition and Epithelial-Mesenchymal Transition via the FGFR/MAPK Signaling Pathway.

Wang M, Sun Y, Zhao Y, Jiang X, Wang T, Xie J Int J Mol Sci. 2025; 26(2).

PMID: 39859240 PMC: 11764546. DOI: 10.3390/ijms26020517.


Novel Integration of Spatial and Single-Cell Omics Data Sets Enables Deeper Insights into IPF Pathogenesis.

Wang F, Jin L, Wang X, Cui B, Yang Y, Duggan L Proteomes. 2025; 13(1.

PMID: 39846634 PMC: 11755616. DOI: 10.3390/proteomes13010003.


Multiscale computational model predicts how environmental changes and treatments affect microvascular remodeling in fibrotic disease.

Leonard-Duke J, Agro S, Csordas D, Bruce A, Eggertsen T, Tavakol T PNAS Nexus. 2024; 4(1):pgae551.

PMID: 39720203 PMC: 11667245. DOI: 10.1093/pnasnexus/pgae551.


Multiscale computational model predicts how environmental changes and drug treatments affect microvascular remodeling in fibrotic disease.

Leonard-Duke J, Agro S, Csordas D, Bruce A, Eggertsen T, Tavakol T bioRxiv. 2024; .

PMID: 38559112 PMC: 10979947. DOI: 10.1101/2024.03.15.585249.

References
1.
Lipson K, Wong C, Teng Y, Spong S . CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012; 5(Suppl 1):S24. PMC: 3368796. DOI: 10.1186/1755-1536-5-S1-S24. View

2.
Jonsdottir H, Arason A, Palsson R, Franzdottir S, Gudbjartsson T, Isaksson H . Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture. Lab Invest. 2015; 95(12):1418-28. DOI: 10.1038/labinvest.2015.114. View

3.
Kusko R, Brothers 2nd J, Tedrow J, Pandit K, Huleihel L, Perdomo C . Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016; 194(8):948-960. PMC: 5067817. DOI: 10.1164/rccm.201510-2026OC. View

4.
Wolters P, Collard H, Jones K . Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2013; 9:157-79. PMC: 4116429. DOI: 10.1146/annurev-pathol-012513-104706. View

5.
Wang X, Park J, Susztak K, Zhang N, Li M . Bulk tissue cell type deconvolution with multi-subject single-cell expression reference. Nat Commun. 2019; 10(1):380. PMC: 6342984. DOI: 10.1038/s41467-018-08023-x. View